164 related articles for article (PubMed ID: 28684899)
1. Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance.
Glantz-Gashai Y; Meirson T; Reuveni E; Samson AO
Drug Des Devel Ther; 2017; 11():1803-1813. PubMed ID: 28684899
[TBL] [Abstract][Full Text] [Related]
2. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
Ren JX; Li CP; Zhou XL; Cao XS; Xie Y
J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799
[TBL] [Abstract][Full Text] [Related]
3. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
Kumar H; Raj U; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2171-83. PubMed ID: 26479578
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1).
Chen L; Wilder PT; Drennen B; Tran J; Roth BM; Chesko K; Shapiro P; Fletcher S
Org Biomol Chem; 2016 Jun; 14(24):5505-10. PubMed ID: 26751150
[TBL] [Abstract][Full Text] [Related]
5. Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.
Detroja TS; Samson AO
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014374
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.
Bruncko M; Wang L; Sheppard GS; Phillips DC; Tahir SK; Xue J; Erickson S; Fidanze S; Fry E; Hasvold L; Jenkins GJ; Jin S; Judge RA; Kovar PJ; Madar D; Nimmer P; Park C; Petros AM; Rosenberg SH; Smith ML; Song X; Sun C; Tao ZF; Wang X; Xiao Y; Zhang H; Tse C; Leverson JD; Elmore SW; Souers AJ
J Med Chem; 2015 Mar; 58(5):2180-94. PubMed ID: 25679114
[TBL] [Abstract][Full Text] [Related]
7. Discovery of selective Mcl-1 inhibitors via structure-based design and structure-activity relationship analysis.
He N; Liu P; Wang Z; Guo Z; Yan X; Chen H; Zhang Z
Biochem Biophys Res Commun; 2019 May; 512(4):921-926. PubMed ID: 30928099
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
[TBL] [Abstract][Full Text] [Related]
9. Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles.
Balazs AYS; Carbajo RJ; Davies NL; Dong Y; Hird AW; Johannes JW; Lamb ML; McCoull W; Raubo P; Robb GR; Packer MJ; Chiarparin E
J Med Chem; 2019 Nov; 62(21):9418-9437. PubMed ID: 31361481
[TBL] [Abstract][Full Text] [Related]
10. Discovery of small molecule inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulation and experimental validation against myeloid cell leukemia-1 (Mcl-1).
Suleiman MR; Wang H; Huang D; Wang H; Joseph J; Huang T; Zhang F; Wang J; Cheng M
J Biomol Struct Dyn; 2021 Apr; 39(7):2512-2525. PubMed ID: 32228162
[TBL] [Abstract][Full Text] [Related]
11. Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
Bourafai-Aziez A; Benabderrahmane M; Paysant H; Weiswald LB; Poulain L; Carlier L; Ravault D; Jouanne M; Coadou G; Oulyadi H; Voisin-Chiret AS; Sopková-de Oliveira Santos J; Sebban M
Drug Des Devel Ther; 2021; 15():5035-5059. PubMed ID: 34949914
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.
Wan Y; Wang J; Sun F; Chen M; Hou X; Fang H
Bioorg Med Chem; 2015 Dec; 23(24):7685-93. PubMed ID: 26620718
[TBL] [Abstract][Full Text] [Related]
13. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
Xu G; Liu T; Zhou Y; Yang X; Fang H
Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.
Wan Y; Dai N; Tang Z; Fang H
Eur J Med Chem; 2018 Feb; 146():471-482. PubMed ID: 29407973
[TBL] [Abstract][Full Text] [Related]
15. Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.
Zhang Z; Su P; Li X; Song T; Chai G; Yu X; Zhang K
Arch Pharm (Weinheim); 2015 Feb; 348(2):89-99. PubMed ID: 25641608
[TBL] [Abstract][Full Text] [Related]
16. Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
Petros AM; Swann SL; Song D; Swinger K; Park C; Zhang H; Wendt MD; Kunzer AR; Souers AJ; Sun C
Bioorg Med Chem Lett; 2014 Mar; 24(6):1484-8. PubMed ID: 24582986
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations.
Offutt TL; Swift RV; Amaro RE
J Chem Inf Model; 2016 Oct; 56(10):1923-1935. PubMed ID: 27662181
[TBL] [Abstract][Full Text] [Related]
18. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
19. DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites.
Gowthaman R; Miller SA; Rogers S; Khowsathit J; Lan L; Bai N; Johnson DK; Liu C; Xu L; Anbanandam A; Aubé J; Roy A; Karanicolas J
J Med Chem; 2016 May; 59(9):4152-70. PubMed ID: 26126123
[TBL] [Abstract][Full Text] [Related]
20. In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically.
Lung J; Chen KL; Hung CH; Chen CC; Hung MS; Lin YC; Wu CY; Lee KD; Shih NY; Tsai YH
Drug Des Devel Ther; 2017; 11():3281-3290. PubMed ID: 29180852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
